[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.209.213. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1984

Hematoporphyrin Photoradiation Therapy for Iris NeovascularizationA Preliminary Report

Author Affiliations

From the Department of Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City.

Arch Ophthalmol. 1984;102(8):1193-1197. doi:10.1001/archopht.1984.01040030971028
Abstract

• Photoradiation therapy is a new technique currently under clinical investigation for the treatment of a variety of solid malignant tumors. The technique involves intravenous (IV) administration of hematoporphyrin derivative, a photosensitizing compound that is preferentially retained by malignant cells, and photoactivation of a neoplasm with red light (630 nm) to obtain selective destruction of cancer cells. A modification of this technique was used to treat iris neovascularization produced in a primate model of retinal vein occlusion. Following IV injection of hematoporphyrin derivative, the anterior surface of the iris was exposed to red light for 30 to 45 minutes. In the four eyes treated, there was a marked reduction of fluorescein leakage from the neovascular tissue within 24 hours following treatment. Histologic examination of two eyes demonstrated a selective response of the iris neovascularization to this therapy, with apparent preservation of surrounding tissue.

References
1.
Schulze RR:  Rubeosis iridis . Am J Ophthalmol 1967;63:487-495.
2.
Gartner S, Henkind P:  Neovascularization of the iris (rubeosis iridis) . Surv Ophthalmol . 1978;22:291-312.Article
3.
Machemer R, Aaberg TM: Vitrectomy . New York, Grune & Stratton Inc, 1979.
4.
Blankenship GW, Machemer R:  Pars plana vitrectomy for the management of severe diabetic retinopathy: An analysis of results five years following surgery . Ophthalmology 1978;35:553-559.Article
5.
Mandelcorn MS, Blankenship GW, Machemer R:  Pars plana vitrectomy for the management of severe diabetic retinopathy . Am J Ophthalmol 1976;81:561-570.
6.
Aaberg TM, van Horn DL:  Late complications of pars plana vitrectomy surgery . Ophthalmology 1978;85:126-140.Article
7.
Faulborn J, Conway BP, Machemer R:  Surgical complications of pars plana vitreous surgery . Ophthalmology 1978;85:116-125.Article
8.
Michels RG:  Vitrectomy for complications of diabetic retinopathy . Arch Ophthalmol 1978; 96:237-246.Article
9.
Rice TA, Michels RG, Maquire MG, et al:  The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy . Am J Ophthalmol 1983;95:1-11.
10.
Dougherty TJ, Kaufman JE, Goldfarb A, et al:  Photoradiation therapy for the treatment of malignant tumors . Cancer Res 1978;38:2628-2635.
11.
Laws ER, Cortese DA, Kinsey JH, et al:  Photoradiation therapy in the treatment of malignant brain tumors: A phase I (feasibility) study . Neurosurgery 1981;9:672-677.Article
12.
Henderson BW, Dougherty TJ: Studies on the mechanism of tumor destruction by photoradiation therapy (PRT). Read at the Clayton Foundation Symposium on Porphyrin Localization and Treatment of Tumors, Santa Barbara,
13.
Calif, April 24-28, 1983.
14.
Virdi PS, Hayreh SS:  Ocular neovascularization with retinal vascular occlusion . Arch Ophthalmol 1982;100:331-341.Article
15.
Ashton M:  Retinal revascularization in health and disease . Am J Ophthalmol 1957;44:7-17.
16.
Patz A, Brem S, Finkelstein D, et al:  A new approach to the problem of retinal neovascularization . Trans Am Acad Ophthalmol Otolaryngol 1978;85:626-637.
17.
Glaser BM, D'Amore PA, Michels RG, et al:  Demonstration of vasoproliferative activity from mammalian retina . J Cell Biol 1980;84:298-304.Article
18.
Mitsui Y, Matsubara M, Kanagawa M:  Fluorescence irido corneal photography . Br J Ophthalmol 1969;53:505-512.Article
19.
Grant WM:  Management of neovascular glaucoma , in Leopold IH (ed): Symposium on Ocular Therapy . St Louis, CV Mosby Co, 1974, vol 7, pp 36-61.
20.
Jacobson DR, Murphy RP, Rosenthal AR:  The treatment of angle neovascularization with panretinal photocoagulation . Ophthalmology 1979;86:1270-1275.Article
21.
Laatikainen L:  Preliminary report on effect of retinal panphotocoagulation on rubeosis iridis and neovascular glaucoma . Br J Ophthalmol 1977;61:278-284.Article
22.
Little HL, Rosenthal AR, Dellaporta A, et al:  The effect of panretinal photocoagulation on rubeosis iridis . Am J Ophthalmol 1976;81:804-809.
23.
Wand M, Dueker DK, Aiello LM, et al:  Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma . Am J Ophthalmol 1978;86:332-339.
24.
The Diabetic Retinopathy Study Research Group:  Preliminary report on effects of photocoagulation therapy . Am J Ophthalmol 1976;81:383-396.
25.
The Diabetic Retinopathy Study Research Group:  Photocoagulation treatment of proliferative diabetic retinopathy: The second report of diabetic retinopathy study findings . Ophthalmology 1978;85:82-106.Article
26.
The Diabetic Retinopathy Study Research Group:  Four risk factors for severe visual loss in diabetic retinopathy: The third report from the diabetic retinopathy study . Arch Ophthalmol 1979;97:654-655.Article
27.
The Diabetic Retinopathy Study Research Group:  Photocoagulation treatment of proliferative diabetic retinopathy: Clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8 . Ophthalmology 1981;88:583-600.Article
28.
Margargal LE, Brown GC, Augsburger JJ, et al:  Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction . Ophthalmology 1982;89:780-783.Article
29.
Simmons RJ, Dueker DK, Kimbrough RL, et al:  Goniophotocoagulation for neovascular glaucoma . Trans Am Acad Ophthalmol Otolaryngol 1977;83:80-89.
30.
Simmons RJ, Depperman SR, Dueker DK:  The role of goniophotocoagulation in neovascularization of the anterior chamber angle . Ophthalmology 1980;87:79-82.Article
31.
Hilton GF:  Panretinal cryotherapy for diabetic rubeosis . Arch Ophthalmol 1979;97:776.Article
32.
May DR, Bergstrom TJ, Parmet AJ, et al:  Treatment of neovascular glaucoma with transscleral panretinal cryotherapy . Ophthalmology 1980;87:1106-1111.Article
33.
Teich SA, Walsh JB:  A grading system for iris neovascularization . Ophthalmology 1981; 88:1102-1106.Article
34.
Weishaupt KR, Gomer CJ, Dougherty TJ:  Identification of singlet oxygen as the cytotoxic agent in photo-inactivation of a murine tumor . Cancer Res 1976;36:2326-2329.
×